Jim Simons acquired 66.2k Kalaris Therapeutics shares worth $308k. That's 0.00% of their equity portfolio (2636th largest holding). Jim Simons started to build up the position in Kalaris Therapeutics in Q1 2025 and continued to invest until Q3 2025. Since then they sold 46.6k shares. The stake costed the investor $189k, netting the investor a gain of 63% so far.